-
Bumrungrad Health Briefing #93: Breast Cancer: Understanding a Diagnosis
31 Oct 2025 11:30 GMT
… Hospital
What Does a Breast Cancer Diagnosis Mean?
A breast cancer diagnosis is not … moving into surrounding tissue). Most breast cancers are invasive ductal carcinoma, while … advanced (III), or advanced/metastatic (IV).
Treatment Pathways
Treatment …
-
A Multicenter Retrospective Analysis on Lymph Node Metastasis in Clinically Node-Negative (cN0) Patients with Small-Sized Breast Cancer
31 Oct 2025 08:19 GMT
… had a single metastatic node, eight cases … metastasis across different molecular subtypes of breast cancer. Luminal-type breast cancers … metastasis according to subtypes of breast cancer. J Breast Cancer. … the origins of breast cancer. Breast Cancer Res Treat. …
-
Encouraging patients with breast cancer: ‘Don’t steal hope’
31 Oct 2025 06:45 GMT
… progress in treatment of breast cancer.
Alpa Patel, senior … begin regular screenings for breast cancer, according to guidelines from … treatments for patients with breast cancer in recent years.
“ … who have been diagnosed with metastatic diseases … they…
-
Patient Stories and Provider Advice Mark Invasive Lobular Breast Cancer Awareness Event
31 Oct 2025 06:20 GMT
… common breast cancer subtype,” said Fred Hutch breast cancer … LeJeunesse, diagnosed with metastatic lobular breast cancer, or mILC, … microcalcifications, another way breast cancers are seen on … “Patients with bone metastasis are excluded from clinical …
-
‘Kisqali drives long-term survival toward complete remission in early breast cancer”
31 Oct 2025 06:04 GMT
… breast cancer patients, and its future applicability.
About 70 percent of all breast cancers … However, additional therapies after metastasis prolong survival, so OS confirmation … Clinicians have used Kisqali in metastatic breast cancer for about seven years, …
-
Shorter, simpler breast cancer treatment: where evidence meets practice
31 Oct 2025 05:26 GMT
… was diagnosed with metastatic HER2-positive breast cancer in December 2021, … treatment for HER2-positive breast cancer for more than two … outcomes across early and metastatic disease. Most patients … shaped the experience of breast cancer therapy. In the ADEPT …
-
<![CDATA[Unmet Needs in Early and Metastatic Breast Cancer]]>
30 Oct 2025 14:24 GMT
… Needs in Early and Metastatic Breast Cancer
Persistent Clinical Challenges and … in hormone receptor-positive breast cancer management. Endocrine resistance … 6 inhibitor management—from metastatic to adjuvant to HER2 … roles in breast cancer care delivery.
-
<![CDATA[Empowering Patients With Early or Metastatic Breast Cancer]]>
30 Oct 2025 14:25 GMT
Empowering Patients With Early or Metastatic Breast Cancer
Patient Empowerment Through Active Self- …
-
Health Canada grants NOC for AstraZeneca’s breast cancer therapy
31 Oct 2025 02:21 GMT
… (trastuzumab deruxtecan) for breast cancer.
The therapy is approved … metastatic hormone receptor (HR)-positive, HER2-low or HER2-ultralow breast cancer … metastatic HER2-low or HER2-ultralow breast cancer … or HER2-ultralow metastatic breast cancer who had not …
-
<![CDATA[Targeting Dormant Tumor Cells: A New Frontier in Preventing Breast Cancer Recurrence]]>
31 Oct 2025 02:24 GMT
… surgery ± systemic therapy), breast cancer cells may be left … before emerging as overt metastatic disease.
Researchers at … study published in Breast Cancer Research demonstrated that dormant … offers hope for transforming breast cancer management from reactive …